Literature DB >> 1895968

A chromosomal study of workers with long-term exposure to radio-frequency radiation.

O M Garson1, T L McRobert, L J Campbell, B A Hocking, I Gordon.   

Abstract

OBJECTIVE: To examine whether an increased level of chromosome damage occurs in the stimulated lymphocytes of radio-linemen after long-term but intermittent exposure to radio-frequency radiation (RFR) during the course of their work. DESIGN AND PARTICIPANTS: Chromosome studies were performed on blood samples from 38 radio-linemen matched by age with 38 controls, all of whom were employed by Telecom Australia. The radio-linemen had all worked with RFR in the range 400 kHz-20 GHz with exposures at or below the Australian occupational limits, and the controls were members of the clerical staff who had no exposure to RFR. Two hundred metaphases from each subject were studied and chromosome damage was scored by an observer who was blind to the status of the subjects.
RESULTS: The ratio of the rate of aberrant cells in the radio-linemen group to that in the control group was 1.0 (95% confidence interval, 0.8-1.3). There were no statistically significant differences in the types of aberrations that were scored.
CONCLUSION: Exposure to RFR at or below the described limits did not appear to cause any increase in chromosomal damage in circulating lymphocytes.

Entities:  

Mesh:

Year:  1991        PMID: 1895968     DOI: 10.5694/j.1326-5377.1991.tb142282.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

1.  Lethal effect of electromagnetic radiation of the millimeter wavelength range on cell cultures of chicken embryo.

Authors:  S A Badzhinyan; A B Sayadyan; N K Sarkisyan; R M Grigoryan; G G Gasparyan
Journal:  Dokl Biochem Biophys       Date:  2001 Mar-Apr       Impact factor: 0.788

Review 2.  A critical review of epidemiologic studies of radiofrequency exposure and human cancers.

Authors:  J M Elwood
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.